<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8666783" created="12//11/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8666783</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Modulation of the expression of the <term id="T1" lex="IFN-gamma_receptor_beta-chain" sem="Protein_molecule">IFN-gamma receptor beta-chain</term> controls responsiveness to <term id="T2" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term> in <term id="T3" lex="human_peripheral_blood_T_cell" sem="Cell_natural">human peripheral blood T cells</term>.</sentence>
<event id="E1">
<type class="Gene_expression"/>
<theme idref="T1"/>
<clue>Modulation of the <clueType>expression</clueType> <linkTheme>of</linkTheme> the IFN-gamma receptor beta-chain controls responsiveness to IFN-gamma in human peripheral blood T cells.</clue>
</event>
<event id="E2">
<type class="Regulation"/>
<theme idref="E1"/>
<clue><clueType>Modulation</clueType> <linkTheme>of</linkTheme> the expression of the IFN-gamma receptor beta-chain controls responsiveness to IFN-gamma in human peripheral blood T cells.</clue>
</event>
<event id="E3">
<type class="Physiological_process"/>
<theme idref="T3"/>
<cause idref="T2"/>
<clue>Modulation of the expression of the IFN-gamma receptor beta-chain controls <clueType>responsiveness</clueType> <linkCause>to</linkCause> IFN-gamma <linkTheme>in</linkTheme> human peripheral blood T cells.</clue>
</event>
<event id="E4">
<type class="Regulation"/>
<theme idref="E3"/>
<cause idref="E2"/>
<clue>Modulation of the expression of the IFN-gamma receptor beta-chain <clueType>controls</clueType> responsiveness to IFN-gamma in human peripheral blood T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T4" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term> has potent <cons id="T5" lex="(AND antiproliferative_effect apoptotic_effect)" sem="(AND Other Other)"><frag id="F1">antiproliferative</frag> and <frag id="F2">apoptotic</frag> <frag id="F3">effects</frag></cons> in <term id="T6" lex="T_cell" sem="Cell_natural">T cells</term> that are important in determining <term id="T7" lex="T_cell_development" sem="Other"><term id="A1" sem="Cell_natural">T cell</term> development</term> and <term id="T8" lex="polarized_differentiation" sem="Other">polarized differentiation</term>.</sentence>
<event KT="Other" id="E5">
<type class="Cellular_physiological_process"/>
<theme idref="A1"/>
<clue>IFN-gamma has potent antiproliferative and apoptotic effects in T cells that are important in determining T cell <clueType>development</clueType> and polarized differentiation.</clue>
</event>
<event KT="Other" id="E6">
<type class="Cell_differentiation"/>
<theme idref="A1"/>
<clue>IFN-gamma has potent antiproliferative and apoptotic effects in T cells that are important in determining T cell development and polarized <clueType>differentiation</clueType>.</clue>
</event>
<event KT="Other" id="E7">
<type class="Cellular_physiological_process"/>
<theme idref="T6"/>
<clue>IFN-gamma has potent anti<clueType>proliferative</clueType> and apoptotic effects <linkTheme>in</linkTheme> T cells that are important in determining T cell development and polarized differentiation.</clue>
</event>
<event KT="Fact" Manner="High" id="E8">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="T4"/>
<clue>IFN-gamma has <clueManner>potent</clueManner> <clueType>anti</clueType>proliferative and apoptotic <clueType>effects</clueType> in T cells that are important in determining T cell development and polarized differentiation.</clue>
</event>
<event KT="Other" id="E109">
<type class="Cellular_physiological_process"/>
<theme idref="T6"/>
<clue>IFN-gamma has potent antiproliferative and <clueType>apoptotic</clueType> effects <linkTheme>in</linkTheme> T cells that are important in determining T cell development and polarized differentiation.</clue>
</event>
<event KT="Fact" Manner="High" id="E110">
<type class="Positive_regulation"/>
<theme idref="E109"/>
<cause idref="T4"/>
<clue>IFN-gamma has <clueManner>potent</clueManner> antiproliferative and apoptotic <clueType>effects</clueType> <linkTheme>in</linkTheme> T cells that are important in determining T cell development and polarized differentiation.</clue>
</event>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="E8"/>
<clue>IFN-gamma has potent antiproliferative and apoptotic effects in T cells that are <clueType>important</clueType> in determining T cell development and polarized differentiation.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="E110"/>
<clue>IFN-gamma has potent antiproliferative and apoptotic effects in T cells that are <clueType>important</clueType> in determining T cell development and polarized differentiation.</clue>
</event>
<sentence id="S3">Therefore, any <term id="A3" sem="Other">event</term> that enables <term id="T9" lex="T_cell" sem="Cell_natural">T cells</term> to become less responsive to <term id="T10" lex="IFN-_gamma" sem="Protein_molecule">IFN- gamma</term> may potentially alter immune responsiveness to <term id="T11" lex="Ag" sem="Protein_family_or_group">Ag</term>.</sentence>
<event KT="Other" id="E12">
<type class="Physiological_process"/>
<theme idref="T9"/>
<cause idref="T11"/>
<clue>Therefore, any event that enables T cells to become less responsive to IFN- gamma may potentially alter <clueType>immune responsiveness</clueType> <linkCause>to</linkCause> Ag.</clue>
</event>
<event KT="Other" id="E13">
<type class="Regulation"/>
<theme idref="T9"/>
<cause idref="T10"/>
<clue>Therefore, any event that enables T cells to become less <clueType>responsive</clueType> <linkCause>to</linkCause> IFN- gamma may potentially alter immune responsiveness to Ag.</clue>
</event>
<event CL="L2" KT="Analysis" id="E14">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="A3"/>
<clue>Therefore, any event that <clueKT><clueCL>enables</clueCL></clueKT> T cells to <clueType>become less</clueType> responsive to IFN- gamma may potentially alter immune responsiveness to Ag.</clue>
</event>
<event CL="L1" KT="Analysis" id="E15" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E12"/>
<cause idref="A3"/>
<clue><clueKT>Therefore</clueKT>, any event that enables T cells to become less responsive to IFN- gamma <clueKT>may</clueKT> <clueCL>potentially</clueCL> <clueType>alter</clueType> immune responsiveness to Ag.</clue>
</event>
<sentence id="S4">In this work, we show that <term id="A4" sem="Cell_natural"><term id="T12" lex="human_peripheral_blood_T_cell" sem="Cell_natural">human peripheral blood T cells</term> that are stimulated through the <term id="T13" lex="TCR" sem="Protein_family_or_group">TCR</term> and expanded with <term id="T14" lex="IL-2" sem="Protein_molecule">IL-2</term></term> are unresponsive to <term id="T15" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term>, as determined by a lack of activation of <term id="T16" lex="jak_kinase" sem="Protein_family_or_group">jak kinases</term> and the <term id="T17" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term>, <term id="T18" lex="STAT1(alpha)" sem="Protein_molecule">STAT1(alpha)</term>, a signal transducer and activator of transcription.</sentence>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E16">
<type class="Positive_regulation"/>
<theme idref="T16"/>
<clue>In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as <clueKT>determined</clueKT> by a <cluePolarity>lack</cluePolarity> of <clueType>activation</clueType> <linkTheme>of</linkTheme> jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E17">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<clue>In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as <clueKT>determined</clueKT> by a <cluePolarity>lack</cluePolarity> of <clueType>activation</clueType> <linkTheme>of</linkTheme> jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E18">
<type class="Regulation"/>
<theme idref="A4"/>
<cause idref="T15"/>
<clue>In this work, we <clueKT>show</clueKT> that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are <clueType><cluePolarity>unresponsive</cluePolarity></clueType> <linkCause>to</linkCause> IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.</clue>
<comment>TPS: A4</comment></event>
<event KT="Other" id="E19">
<type class="Physiological_process"/>
<theme idref="T12"/>
<cause idref="T13"/>
<clue>In this work, we show that human peripheral blood T cells that are <clueType>stimulated</clueType> <linkCause>through</linkCause> the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.</clue>
</event>
<event KT="Other" id="E61">
<type class="Physiological_process"/>
<theme idref="T12"/>
<cause idref="T14"/>
<clue>In this work, we show that human peripheral blood T cells that are stimulated through the TCR and <clueType>expanded</clueType> <linkCause>with</linkCause> IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.</clue>
</event>
<sentence id="S5">This nonresponsiveness occurs because of a lack of expression of the <term id="A5" sem="Protein_substructure"><term id="T19" lex="beta-_chain" sem="Protein_molecule">beta- chain</term> (accessory factor) of the <term id="T20" lex="IFN-gamma_receptor" sem="Protein_molecule">IFN-gamma receptor</term></term>, while at the same time maintaining <term id="T21" lex="IFN-gamma_receptor_alpha-chain_expression" sem="Other"><term id="T22" lex="IFN-gamma_receptor_alpha-chain" sem="Protein_molecule"><term id="T23" lex="IFN-gamma_receptor" sem="Protein_molecule">IFN-gamma receptor</term> alpha-chain</term> expression</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E20">
<type class="Gene_expression"/>
<theme idref="A5"/>
<clue>This nonresponsiveness occurs because of a <cluePolarity>lack</cluePolarity> of <clueType>expression</clueType> <linkTheme>of</linkTheme> the beta- chain (accessory factor) of the IFN-gamma receptor, while at the same time maintaining IFN-gamma receptor alpha-chain expression.</clue>
<comment>TPS: A5</comment></event>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="E20"/>
<clue><corefTheme>This nonresponsiveness</corefTheme> <clueType>occurs</clueType> <linkCause>because of</linkCause> a lack of expression of the beta- chain (accessory factor) of the IFN-gamma receptor, while at the same time maintaining IFN-gamma receptor alpha-chain expression.</clue>
</event>
<event id="E22">
<type class="Gene_expression"/>
<theme idref="T22"/>
<clue>This nonresponsiveness occurs because of a lack of expression of the beta- chain (accessory factor) of the IFN-gamma receptor, while at the same time maintaining IFN-gamma receptor alpha-chain <clueType>expression</clueType>.</clue>
</event>
<sentence id="S6">Expression of the <term id="T24" lex="beta-chain" sem="Protein_molecule">beta-chain</term> can be restored by secondary <term id="T25" lex="TCR" sem="Protein_family_or_group">TCR</term> ligation or <term id="T26" lex="PMA_treatment" sem="Other"><term id="T27" lex="PMA" sem="Organic_compound_other">PMA</term> treatment</term>.</sentence>
<event KT="Other" id="E23">
<type class="Gene_expression"/>
<theme idref="T24"/>
<clue><clueType>Expression</clueType> <linkTheme>of</linkTheme> the beta-chain can be restored by secondary TCR ligation or PMA treatment.</clue>
</event>
<event KT="Other" id="E24">
<type class="Binding"/>
<theme idref="T25"/>
<clue>Expression of the beta-chain can be restored by secondary TCR <clueType>ligation</clueType> or PMA treatment.</clue>
</event>
<event KT="Method" id="E25">
<type class="Artificial_process"/>
<theme idref="T27"/>
<clue>Expression of the beta-chain can be restored by secondary TCR ligation or PMA <clueType>treatment</clueType>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E26">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="E24"/>
<clue>Expression of the beta-chain <clueKT><clueCL>can</clueCL></clueKT> be <clueType>restored</clueType> <linkCause>by</linkCause> secondary TCR ligation or PMA treatment.</clue>
</event>
<event CL="L2" KT="Analysis" id="E27">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="E25"/>
<clue>Expression of the beta-chain <clueKT><clueCL>can</clueCL></clueKT> be <clueType>restored</clueType> <linkCause>by</linkCause> secondary TCR ligation or PMA treatment.</clue>
</event>
<sentence id="S7"><term id="T28" lex="T_cell_blast" sem="Cell_natural">T cell blasts</term> treated with <term id="T29" lex="PMA" sem="Organic_compound_other">PMA</term> are now responsive to <term id="T30" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term>.</sentence>
<event KT="Method" id="E28">
<type class="Artificial_process"/>
<theme idref="T28"/>
<theme idref="T29"/>
<clue>T cell blasts <clueType>treated</clueType> <linkTheme>with</linkTheme> PMA are now responsive to IFN-gamma.</clue>
</event>
<event id="E29">
<type class="Regulation"/>
<theme idref="T28"/>
<cause idref="T30"/>
<clue>T cell blasts treated with PMA are now <clueType>responsive</clueType> <linkCause>to</linkCause> IFN-gamma.</clue>
</event>
<event id="E30">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="E28"/>
<clue>T cell blasts treated with PMA are now responsive to IFN-gamma.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S8">When <term id="A6" sem="Cell_natural">freshly isolated, highly enriched (&gt;98%) <term id="T31" lex="T_cell" sem="Cell_natural">T cells</term></term> are examined for <term id="T32" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term> responsiveness; these cells can respond to <term id="T33" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term> and express <term id="T34" lex="beta-chain" sem="Protein_molecule">beta-chain</term>.</sentence>
<event KT="Investigation" id="E31" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="A6"/>
<cause idref="T32"/>
<clue>When freshly isolated, highly enriched (&gt;98%) T cells are <clueKT>examined</clueKT> <linkCause>for</linkCause> IFN-gamma <clueType>responsiveness</clueType>; these cells can respond to IFN-gamma and express beta-chain.</clue>
</event>
<event CL="L2" KT="Analysis" id="E32">
<type class="Regulation"/>
<theme idref="A6"/>
<cause idref="T33"/>
<clue>When freshly isolated, highly enriched (&gt;98%) T cells are examined for IFN-gamma responsiveness; <linkTheme>these cells</linkTheme> <clueKT><clueCL>can</clueCL></clueKT> <clueType>respond</clueType> <linkCause>to</linkCause> IFN-gamma and express beta-chain.</clue>
</event>
<event CL="L2" KT="Analysis" id="E33">
<type class="Gene_expression"/>
<theme idref="T34"/>
<clue>When <clueLoc>freshly isolated, highly enriched (&gt;98%) T cells</clueLoc> are examined for IFN-gamma responsiveness; these cells <clueKT><clueCL>can</clueCL></clueKT> respond to IFN-gamma and <clueType>express</clueType> beta-chain.</clue>
</event>
<sentence id="S9">Therefore, as <term id="T35" lex="T_cell" sem="Cell_natural">T cells</term> progress from primary <term id="T36" lex="TCR" sem="Protein_family_or_group">TCR</term> activation through <term id="T37" lex="IL-2" sem="Protein_molecule">IL-2</term>-dependent proliferation, followed by <term id="T38" lex="secondary_TCR_stimulation" sem="Other">secondary <term id="T39" lex="TCR" sem="Protein_family_or_group">TCR</term> stimulation</term>, their responsiveness to <term id="T40" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term> varies, and this may affect their ability to participate in an ongoing <term id="T41" lex="immune_response" sem="Other">immune response</term>.</sentence>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="T36"/>
<clue>Therefore, as T cells progress from primary TCR <clueType>activation</clueType> through IL-2-dependent proliferation, followed by secondary TCR stimulation, their responsiveness to IFN-gamma varies, and this may affect their ability to participate in an ongoing immune response.</clue>
</event>
<event id="E135">
<type class="Cellular_physiological_process"/>
<theme idref="T35"/>
<clue>Therefore, as T cells progress from primary TCR activation through IL-2-dependent <clueType>proliferation</clueType>, followed by secondary TCR stimulation, their responsiveness to IFN-gamma varies, and this may affect their ability to participate in an ongoing immune response.</clue>
</event>
<event id="E136">
<type class="Positive_regulation"/>
<theme idref="E135"/>
<cause idref="T37"/>
<clue>Therefore, as T cells progress from primary TCR activation through IL-2-<clueType>dependent</clueType> proliferation, followed by secondary TCR stimulation, their responsiveness to IFN-gamma varies, and this may affect their ability to participate in an ongoing immune response.</clue>
</event>
<event id="E36">
<type class="Positive_regulation"/>
<theme idref="T39"/>
<clue>Therefore, as T cells progress from primary TCR activation through IL-2-dependent proliferation, followed by secondary TCR <clueType>stimulation</clueType>, their responsiveness to IFN-gamma varies, and this may affect their ability to participate in an ongoing immune response.</clue>
</event>
<event KT="Analysis" id="E37">
<type class="Regulation"/>
<theme idref="T35"/>
<cause idref="T40"/>
<clue><clueKT>Therefore</clueKT>, <clueTime>as T cells progress from primary TCR activation through IL-2-dependent proliferation, followed by secondary TCR stimulation</clueTime>, <corefTheme>their</corefTheme> <clueType>responsiveness</clueType> <linkCause>to</linkCause> IFN-gamma varies, and this may affect their ability to participate in an ongoing immune response.</clue>
</event>
<event KT="Other" id="E38">
<type class="Correlation"/>
<theme idref="T35"/>
<theme idref="T41"/>
<clue>Therefore, as T cells progress from primary TCR activation through IL-2-dependent proliferation, followed by secondary TCR stimulation, their responsiveness to IFN-gamma varies, and this may affect their ability to <clueType>participate</clueType> <linkTheme>in</linkTheme> an ongoing immune response.</clue>
</event>
<event CL="L1" KT="Analysis" id="E39" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E38"/>
<cause idref="E37"/>
<clue><clueKT>Therefore</clueKT>, as T cells progress from primary TCR activation through IL-2-dependent proliferation, followed by secondary TCR stimulation, their responsiveness to IFN-gamma varies, and this <clueCL>may</clueCL> <clueType>affect</clueType> their ability to participate in an ongoing immune response.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
